Abstract B29: AXL Inhibitor TP-0903 attenuates TGFβ-Hippo signaling in lung adenocarcinoma cells

MLA

Steve Warner, et al. “Abstract B29: AXL Inhibitor TP-0903 Attenuates TGFβ-Hippo Signaling in Lung Adenocarcinoma Cells.” Molecular Cancer Research, vol. 18, Aug. 2020, p. B29. EBSCOhost, https://doi.org/10.1158/1557-3125.hippo19-b29.

APA

Steve Warner, Chia-Nung Hung, Nicholas D. Lucio, Chiou-Miin Wang, David J. Bearss, Lars Mouritsen, Nameer B. Kirma, Daniel T. DeArmond, Mark Wade, Meizhen Chen, Josephine A. Taverna, Lianquin Qiu, Tim H M Huang, Alia Nazarullah, Chih-Wei Chou, Shellye R. Lampkin, Chun-Lin Lin, Pawel A. Osmulski, Ruben A. Mesa, & Maria Gaczynska. (2020). Abstract B29: AXL Inhibitor TP-0903 attenuates TGFβ-Hippo signaling in lung adenocarcinoma cells. Molecular Cancer Research, 18, B29. https://doi.org/10.1158/1557-3125.hippo19-b29

Chicago

Steve Warner, Chia-Nung Hung, Nicholas D. Lucio, Chiou-Miin Wang, David J. Bearss, Lars Mouritsen, Nameer B. Kirma, et al. 2020. “Abstract B29: AXL Inhibitor TP-0903 Attenuates TGFβ-Hippo Signaling in Lung Adenocarcinoma Cells.” Molecular Cancer Research 18 (August): B29. doi:10.1158/1557-3125.hippo19-b29.